On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program ...

Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.

Anne Schmitz, University of Wisconsin-Stout and Daniel Freedman, University of Wisconsin-Stout (THE CONVERSATION) Three-dimensional printing is transforming medical care, letting the health care field ...

High-density design makes EdgeCore’s Mesa, Arizona data centers a near-term solution for hyperscale AI and cloud applications ...

Cortechs.ai has announced a strategic partnership with ALZ-NET aimed at improving the quality of care for Alzheimer's.

AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its ...

Heart Test Laboratories, Inc. ( ($HSCS) ) just unveiled an announcement. HeartSciences Inc. has been granted an extension by Nasdaq to regain ...

Gaming for health! Maria Clara Mesa uses gamification & behavioral science to create digital health solutions. Learn how play ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

Hannah Koczka, vice president for NM Ventures and Innovation at Northwestern Medicine, shares a structured approach to ...

Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...

If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...